What you have to show before you do a screening programme

M. Law (London, United Kingdom)

Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Session: A sceptical look at lung cancer screening
Session type: Symposium
Number: 4415
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Law (London, United Kingdom). What you have to show before you do a screening programme. Annual Congress 2005 - A sceptical look at lung cancer screening

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What might its impact really be in Europe?
Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Year: 2005

Screening
Source: Eur Respir J 2003; 21: 3S-15S
Year: 2003



The impact of a lung cancer computed tomography screening result on smoking abstinence
Source: Eur Respir J 2011; 37: 1466-1473
Year: 2011



The efficacy of COPD detection by using a community-based annual screening program for lung cancer
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012


Current situation of a smoking cessation and lung cancer screening programme in a Spanish third level hospital
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008

The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey
Source: ERJ Open Res, 6 (1) 00158-2019; 10.1183/23120541.00158-2019
Year: 2020



The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


Early detection of COPD is important for lung cancer surveillance
Source: Eur Respir J 2012; 39: 1230-1240
Year: 2012



The prevention of occupational asthma
Source: Eur Respir J 2003; 22: 853-860
Year: 2003



Predictors of smoking cessation within a lung cancer CT screening trial
Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Year: 2011

Smoking habits are unaffected by CT screening at 1 year follow up in the Danish lung cancer screening trial (DLCST)
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Participation in a targeted lung health check program and smoking cessation.
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020


Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010

The feasibility of a lung cancer screening program in rural Ireland
Source: Eur Respir J 2006; 28: Suppl. 50, 80s
Year: 2006

Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019


Improving asthma outcomes through community pharmacy intervention
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006